Literature DB >> 8348741

Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa.

S S Pierangeli1, G Sonnenfeld.   

Abstract

Murine interferon-gamma (MuIFN-gamma) and murine tumour necrosis-alpha (MuTNF-alpha) are known to be potent immunomodulators of several aspects of the immune response, and they have been shown to exert profound effects on macrophages and monocytes. The purpose of this study was to determine the effects of MuIFN-gamma and MuTNF-alpha on the phagocytosis (uptake and intracellular killing) of opsonized Pseudomonas aeruginosa. Unstimulated peritoneal macrophages obtained from CBA/c mice were exposed to different concentrations of recombinant forms of the cytokines (rMuIFN-gamma and rMuTNF-alpha) for different periods of time. Phagocytosis was assayed using different concentrations of opsonized Ps. aeruginosa. In all cases the pretreatment of the cells with the cytokines increased significantly the uptake and the intracellular killing of bacteria in a dose-dependent manner. rMuTNF-alpha was effective only at 1000 U/ml. Combined treatment with the cytokines showed a less than additive effect with rMuIFN-gamma and rMuTNF-alpha at concentrations of 10 U/ml and 100 U/ml. In the in vivo experiments, peritoneal macrophages obtained from rMuIFN-gamma- or rMuTNF-alpha-treated mice showed enhancement of the intracellular killing of opsonized bacteria in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348741      PMCID: PMC1554826          DOI: 10.1111/j.1365-2249.1993.tb07960.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Pseudomonas aeruginosa infection: pathogenesis and therapy.

Authors:  J E Pennington
Journal:  Compr Ther       Date:  1979-05

Review 2.  Burn wounds: microbiology, local host defenses, and current therapy.

Authors:  P Nathan; I A Holder; B G MacMillan
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-07

3.  Role of interferon in experimental mouse malaria.

Authors:  W W Schultz; K Y Huang; F B Gordon
Journal:  Nature       Date:  1968-11-16       Impact factor: 49.962

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease.

Authors:  F Kierszenbaum; G Sonnenfeld
Journal:  J Parasitol       Date:  1982-04       Impact factor: 1.276

6.  Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi.

Authors:  G Sonnenfeld; F Kierszenbaum
Journal:  Am J Trop Med Hyg       Date:  1981-11       Impact factor: 2.345

7.  Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; I Dubbeldeman-Rempt; R van Furth
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

8.  Antiproliferative activity of highly purified mouse interferon: brief communication.

Authors:  R F Buffett; M Ito; A M Cairo; W A Carter
Journal:  J Natl Cancer Inst       Date:  1978-01       Impact factor: 13.506

9.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Alterations of macrophage functions by mediators from lymphocytes.

Authors:  C F Nathan; M L Karnovsky; J R David
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  6 in total

1.  Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.

Authors:  G B Pier; M Grout; T S Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Cholecystokinin protects rats against sepsis induced by Staphylococcus aureus.

Authors:  Fabiana Maria das Graças Corsi Zuelli; Evelin Capellari Cárnio; Rafael Simone Saia
Journal:  Med Microbiol Immunol       Date:  2014-02-01       Impact factor: 3.402

3.  Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa.

Authors:  C Morissette; C Francoeur; C Darmond-Zwaig; F Gervais
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.

Authors:  A Buret; M L Dunkley; G Pang; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Morphological and Functional Alterations of Alveolar Macrophages in a Murine Model of Chronic Inflammatory Lung Disease.

Authors:  Julia Désirée Boehme; Sabine Pietkiewicz; Inna Lavrik; Andreas Jeron; Dunja Bruder
Journal:  Lung       Date:  2015-08-30       Impact factor: 2.584

Review 6.  TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.

Authors:  Edin J Mifsud; Amabel C L Tan; David C Jackson
Journal:  Front Immunol       Date:  2014-03-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.